{
  "issueKey": "{{<URL>y}}",
  "summary": "{{<URL>mmary}}",
  "description": "{{<URL>scription}}",
  "comment": "{{<URL>dy}}",
  "labels": "{{<URL>bels}}",
  "status": "{{<URL>}}",
  "assignee": "{{<URL>signee.displayName}}",
  "updated": "{{<URL>elds.updated}}"
}


RESPONSE


{ "issueKey": "<PERSON>", "summary": "RE: MDM Database Export", "description": "Hi <PERSON>, As you requested reports we have shared. So, we are closing this ticket. Regards Deepan *From:* Paulraj, Deepanraj *Sent:* <DATE_TIME> *To:* <LOCATION>, <PERSON> <<EMAIL_ADDRESS>>; <ORGANIZATION> <<EMAIL_ADDRESS>> *Cc:* DL-ATP_MDMHUB_SUPPORT_PROD <<EMAIL_ADDRESS>> *Subject:* RE: MDM Database Export Hi <PERSON>, Please find the attached file. Regards Deepan *From:* Paulraj, Deepanraj *Sent<DATE_TIME> *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Cc:* DL-ATP_MDMHUB_SUPPORT_PROD <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: MDM Database Export Hi [@Veberič, <ORGANIZATION>], Below request is acknowledge with <NRP> ticket no: *IM44430883* Currently, we have started to export these reports, once completed we will share you. Regards Deepan *From<LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* DL-ATP_MDMHUB_SUPPORT_PROD <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* FW: <ORGANIZATION>, I was referred to you by [<ORGANIZATION>, KOMAL|mailto:<EMAIL_ADDRESS>]. I'm interested in obtaining an export via MDM that includes *approved speakers per country and their last briefing date.* Specifically, I require data for *all <LOCATION> countries,* including <LOCATION>, <LOCATION>, <LOCATION>, and <LOCATION>. Thank you in advance! Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From:* <ORGANIZATION>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: MDM Database Export Hi [@Veberič, <ORGANIZATION>], Thank you for reaching out. However, the below markets are currently not available in <ORGANIZATION>. Please reach out to HUB and <ORGANIZATION> team for exports. [<EMAIL_ADDRESS><URL> [<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>] Regards, Komal *From<LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* <ORGANIZATION>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* MDM Database Export Dear Komal, I was referred to you by [@Kesisoglou, <ORGANIZATION>]. I'm interested in obtaining an export via MDM that includes *approved speakers per country and their last briefing date.* Specifically, I require data for *all <LOCATION> countries,* including <LOCATION>, <LOCATION>, <LOCATION>, and <LOCATION>. Thank you in advance! Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From<PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Cc:* Bojic Kek, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program Policy Hello dear <PERSON>, Since <PERSON> is on leave, I would like to inform you that we discussed your query along with our global team in our previous catch up and we concluded that <ORGANIZATION> can currently not provide any export that would contain approved speakers with expiration/renewal date. This export although could be made via MDM database. Kindly refer to [<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>] who has provided to us such an export for <LOCATION> <DATE_TIME>. Even there although, despite the fact that we may see if an <ORGANIZATION> is approved, we can see only his/her last briefing date and not the expiration date: !<PERSON>! In any case, I believe an extract like this for now would be a good start for your market so as to begin maintaining an approved speaker list till any future enhancement in <ORGANIZATION> reporting/exporting system. Best Regards, !<URL>g|thumbnail!!<URL>g|thumbnail! *From**:* Veberič, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent**:* <DATE_TIME> *To**:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Cc**:* Bojic Kek, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject**:* RE: Update to Global Speaker Program <PERSON>, I wanted to follow-up on my previous email regarding Section 2.3 – can we generate a country-specific list of approved speakers from the <ORGANIZATION> Navigator system (e.g. export Excel)? Is it possible to view the approval date of each speaker and their expiration date for renewal within the <ORGANIZATION> system? Thanks in advance for your feedback! Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From<LOCATION>, Barbara *Sent<DATE_TIME> 11:38 AM *To:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program <PERSON>, Very helpful. Thank you! Regarding Section 2.3 (Speakers – Approved List and Periodic Checks) – can we generate a country-specific list of approved speakers from the <ORGANIZATION> Navigator system (e.g. export Excel)? Is it possible to view the approval date of each speaker and their expiration date for renewal within the <ORGANIZATION> system? Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program <PERSON>. Sorry I missed your email please see below my answers below in green. Let me please if you need any further details Best Regards Mariem *From<LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME>, 2024 <DATE_TIME> *To:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program <PERSON>, Thank you once again! I still need some clarification on policy sections 2.3 and 2.5 – please see below. Regarding Section 2.3 (Speakers – Approved List and Periodic Checks), I understand that our local <ORGANIZATION> colleagues will maintain the updated list of qualified and approved speakers. However, I would like to know *who can assist our market in setting up a speaker lis**t.* {color:#70AD47}Not sure I I got well this time your question{color} {color:#70AD47}😊{color}{color:#70AD47} The approved speaker list is maintained in <ORGANIZATION> (Navigator HCP database). As long as there are historical transactions with speakers approved, they will be automatically saved in <ORGANIZATION> and will be expired after <DATE_TIME>. You do not need to separately maintain a speaker list.{color} Additionally, concerning Section 2.5 (Speaker Materials and Content), the policy states that markets using the <ORGANIZATION> Navigator system should upload approved speaker program content and its respective medical approval into the system. My question is *whether <ORGANIZATION> can serve as the sole archive for speaker program content, or if we need to maintain a separate local archive in a centralized local repository.:* {color:#70AD47}Agreed <LOCATION> can be a central repository for external created content and its approval. However, for internal core deck, it still needs to go through <ORGANIZATION> and it is governed by medical team{color} Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program Policy Dear <PERSON> I am very pleased to assist ! Kindly note below my comments in <ORGANIZATION> please don’t hesitate if you have further questions & clarifications. Best Regards | *{color:black} *<PERSON> Abdallah*{color}*{color:black} EMEA Speaker Program & Policy operations Senior Manager{color} | | | | *{color:#0000C9} *Meetings, <ORGANIZATION> (MEET)*{color}*{color:black} Your Journey, Our Priority!{color} | *From<LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> 9:20 AM *To:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program Policy <PERSON>, Thank you for your feedback. I still have a few remaining questions—apologies for the back-and-forth. * Is Version #3 of the GSPP, last updated in <DATE_TIME>, the final version of the policy that will be effective from <DATE_TIME>? {color:#70AD47}YES effective date for all update will be <ORGANIZATION> 15th{color} * Could we arrange local training sessions for relevant colleagues on the updated GSPP before its effective date, for example in <DATE_TIME>? {color:#70AD47}MEET regional speaker program team will set up meetings to go through the policy updates and operational requirement with market stakeholders in <DATE_TIME>. In between Please feel free to contact myself and <PERSON> cc’d above if you have any other questions before the meeting. Also <PERSON> in case there is any insight from local compliance perspective.{color} Additionally, I have specific questions regarding the policy sections: * Section 2.3 Speakers – Approved List and Periodic Checks: Who can assist us in establishing and maintaining an approved list of speakers? {color:#70AD47}Medical Affairs colleague will be suuporting on that please refer to section 3 in Roles & Responsibilities as well in the policy as per the below screen shot{color} !<URL>g|thumbnail! * {color:#70AD47} {color}{color:windowtext}Section 2.5 Speaker Materials and Content – Retention: Can we exclusively utilize the <ORGANIZATION> Navigator system for storing final versions of speaker program presentations and their corresponding medical approval emails? This would allow us to remove archives from our centralized local repositories as per the <DATE_TIME> version of the GSPP, which requires final, approved Speaker Program content to be uploaded into <ORGANIZATION> Navigator post-delivery, along with evidence of review and approval.{color} {color:#70AD47}This is the expectation from the policy : for <ORGANIZATION> Mapp Navigator final, approved Speaker Program content must be uploaded in{color} Thanks again! Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME>, 2024 3:20 PM *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program Policy Dear <PERSON>. Kindly see below my comments Let me know please if this clear for you. Regards Mariem *From<LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> 8:17 AM *To:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program <PERSON>, Thank you for clarifying. I also have a few additional questions: * Who can assist us with updating the local SOP if we choose to maintain it as a reference? {color:#2B9B62}as stated, the expectation is to remove the local SOP from Markets , All local requirements should have been transitioned to <ORGANIZATION> ( CAP ) and any future updates should be made therein to respond to your question if you prefer keep it the Local <ORGANIZATION> will be responsible for updating it in alignment with the global Policy : Local SOP should be as consistent as the CAP{color} * Will training on the updated version of the GSPP be available before its effective date? {color:#2B9B62}Global SPP Training including updates will be launched by the End of this year.{color} Can we obtain core slides for the updated GSPP to facilitate local-level training sessions? {color:#2B9B62}Please refer to the <ORGANIZATION> attached in Global the communication - I am attaching also for your reference a different version of comparisons between the old policy language and the new language. It’s not every tiny change but includes the main updates that we made in the latest version. It’s not perfectly cleaned up, but hopefully will do the trick for now.{color} Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> *To:* <LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* RE: Update to Global Speaker Program Policy Dear <PERSON>. Thank you for reaching out to us. Indeed, the update will be effective by <DATE_TIME>, these updates should be reflected into the CAP of each <ORGANIZATION> section) ; if you may see in the update the expectation is to remove the local <ORGANIZATION> local requirements should have been transitioned to <ORGANIZATION> ( CAP ) and any future updates should be made therein unless the <ORGANIZATION> has a business reason to keep it as a reference hence in this case both local <ORGANIZATION> must be accurate & consistent . We as Speaker Program Team are the owner of this policy and certainly will liase with you & [@Bojic Kek, Marjeta|mailto:<EMAIL_ADDRESS>] to make this update consistent & clear across the Market . ( you can refer to the section Roles & Responsibilities in Page 15 -17 Hope this clarifies your query , otherwise please let me know if you have further question happy to assist <ORGANIZATION> | *{color:black} *<PERSON> Abdallah*{color}*{color:black} EMEA Speaker Program & Policy operations Senior Manager{color} | | | | *{color:#0000C9} *Meetings, <ORGANIZATION> (MEET)*{color}*{color:black} Your Journey, Our Priority!{color} | *From<LOCATION>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME>, 2024 <DATE_TIME> *To:* <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]>; <PERSON>, <PERSON> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Cc:* Bojic Kek, <ORGANIZATION> <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* FW: Update to Global Speaker Program Policy Dear Colleagues, My name is <PERSON>, and I have recently assumed the role of <ORGANIZATION> Manager for the <LOCATION> region, succeeding <PERSON>, who will retire on <DATE_TIME>. <PERSON> currently oversees the local Speaker Program Policy SOP for the <LOCATION> region and its <ORGANIZATION> for <LOCATION>, <LOCATION>, <LOCATION>, <LOCATION>, and <ORGANIZATION>. As I take on this responsibility, I will serve as the interim owner until the updated version comes into effect. According to recent communications, there is a planned transfer of ownership for GSPP and an update to the policy, scheduled to take effect on <DATE_TIME>. *I am seeking clarification on how these changes will impact our markets, particularly regarding the transfer of ownership, updates to local SOPs aligned with global policies, and revisions to local country annexes.* Your guidance during this transition period would be greatly appreciated, and I kindly request to be kept informed of any developments moving forward. Thanks in advance! Best, Barbara *{color:#0000C9} *<PERSON>, MPharm*{color}* {color:#0000C9}Medical Quality Governance Manager (MQGM) <ORGANIZATION>} {color:#0000C9}{color} *{color:#0000C7} *IDM Medical Affairs*{color}*{color:#0000C7}{color} {<ORGANIZATION> Ljubljana{color} {color:#0000C7}Letališka cesta 29a, 1000 <LOCATION>, SIovenia{color} *{color:#0000C7} *M*{color}*{color:#0000C7}: <PHONE_NUMBER>{color} *{color:#0000C7} {color}* *{color:#A6A6A6} *CONFIDENTIALITY NOTICE*{color}*{color:#A6A6A6}: _This e-mail message from <ORGANIZATION>, <ORGANIZATION> (including all attachments) is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies. If you wish to report an adverse event, please contact_{color} [ _{color:#A6A6A6} _<URL>Reporting@<URL>_{color}_|mailto:<EMAIL_ADDRESS>] _{color:#A6A6A6} _._{color}_ *From:* Global Speaker Program and Policy <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Sent:* <DATE_TIME> 21:14 *To:* No reply <[<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]> *Subject:* Update to Global Speaker Program Policy Dear Colleagues. We hope all is well at your end. As you may be aware, over <DATE_TIME>, the Compliance team, and <ORGANIZATION>, <ORGANIZATION>, and <ORGANIZATION> team (GBS MEET PI&C) have been working to transition the ownership of <ORGANIZATION>, which was previously managed by the Global Risk Lead within Compliance. In parallel, we received endorsement from the <ORGANIZATION> (CQRC) to build a team within the GBS MEET PI&C organization to support operationalization of speaker program requirements within markets across {color:black} the respective regions (<ORGANIZATION>, <ORGANIZATION>, and APAC).{color} The objective of this new team is to further streamline operations across markets while enhancing overall efficiency and strengthening risk management. We look forward to receiving your continued attention and support during this crucial period of transition as the team assumes their new responsibilities. Below is an overview of the GBS MEET PI&C team that will support the Global Policy and Process Oversight:{color:black}{color} | *Global Contacts* | ? <PERSON> (Sr. Director, Global MEET PI&C Lead) ? <PERSON> (Director, MEET <ORGANIZATION> and <ORGANIZATION> Policy Owner) | | *Regional Contacts* | *APAC :* * <PERSON> (Sr. Manager - MEET PI&C APAC Regional Lead)* <PERSON> (Sr. Analyst - MEET PI&C APAC Region) | | *EMEA (excluding <LOCATION> and <LOCATION>):* * <PERSON> (Sr. Manager - <ORGANIZATION>) * <PERSON> (Sr. Analyst - EMEA Region) | | *LATAM : and including <LOCATION>, <LOCATION>, and <LOCATION>* * <PERSON> (Director - MEET PI&C) * <PERSON> (Sr. Manager - MEET LATAM Regional Lead) * <PERSON> (Sr. Analyst - LATAM Region) | <ORGANIZATION> (Global Risk Lead for <ORGANIZATION>) will continue to partner and support the GBS MEET PI&C team in managing <ORGANIZATION> going forward. We have made updates to <ORGANIZATION> to incorporate updated roles & responsibilities of various functions associated with speaker programs, including the new responsibilities for GBS MEET PI&C, as well as to clarify certain policy requirements. The updated policy will become effective on *{color:#00B050} *<DATE_TIME>, 2024.*{color}* The updated policy and a summary of the recent updates are attached to this email. Please cascade this message to your team and other relevant colleagues, as needed. In <DATE_TIME>, GBS MEET PI&C Regional teams will be reaching out to colleagues in the Markets to support the transition and will partner with market Compliance to update the requirements within the local <LOCATION>, as needed. Your cooperation and commitment to adapting these changes are greatly appreciated. If you have any questions or concerns, please feel free to reach out to the above mentioned contact points or to our mailbox at [<EMAIL_ADDRESS>|mailto:<EMAIL_ADDRESS>]. *Best regards,* *<PERSON>, GBS MEET PI&C Lead & Alison Page, Global Risk Lead*", "comment": "Thank you for the update. !<PERSON>! !<PERSON>! !<URL>g|thumbnail!, <PERSON>, please help me, MDM HUB   please help me respond, <ORGANIZATION> can you respond please, MDM team, we need a status update", "labels": "mdm_escalation", "status": "Canceled", "assignee": "<PERSON>, <PERSON>", "updated": "<DATE_TIME>" }